News
CPHI
0.3280
-2.44%
-0.0082
Weekly Report: what happened at CPHI last week (0408-0412)?
Weekly Report · 3d ago
Weekly Report: what happened at CPHI last week (0401-0405)?
Weekly Report · 04/08 12:34
CPHI Stock Earnings: China Pharma Holding Reported Results for Q4 2023
China Pharma Holding just reported results for the fourth quarter of 2023. The company reported earnings per share of -73 cents and revenue of $2.15 million. China Pharma Holding reported revenue of -$1.7 million. The stock is down 2.7% in the last week.
Investorplace · 04/05 09:52
Weekly Report: what happened at CPHI last week (0325-0329)?
Weekly Report · 04/01 12:29
12 Health Care Stocks Moving In Monday's Pre-Market Session
Galera Therapeutics (NASDAQ:GRTX) shares moved upwards by 62.8% to $0.23 during Monday's pre-market session. China Pharma Holdings, Inc. Common Stock (AMEX:CPHI) stock rose 14.76% in the pre- market session. Sunshine Biopharma ( NASDAQ:SBFM) shares also rose.
Benzinga · 04/01 12:08
Weekly Report: what happened at CPHI last week (0318-0322)?
Weekly Report · 03/25 12:33
Weekly Report: what happened at CPHI last week (0311-0315)?
Weekly Report · 03/18 12:32
Weekly Report: what happened at CPHI last week (0304-0308)?
Weekly Report · 03/11 12:25
Weekly Report: what happened at CPHI last week (0226-0301)?
Weekly Report · 03/04 12:30
12 Health Care Stocks Moving In Friday's After-Market Session
Ainos (NASDAQ:AIMD) stock moved upwards by 54.3% to $1.62 during Friday's after-market session. Aadi Bioscience and Taysha Gene Therapies stock also rose during the session. Losers Healthcare Triangle stock fell 8.1% during the same time period.
Benzinga · 03/01 21:32
Weekly Report: what happened at CPHI last week (0219-0223)?
Weekly Report · 02/26 12:51
China Pharma Holdings Announces Reverse Stock Split
TipRanks · 02/24 14:59
12 Health Care Stocks Moving In Friday's After-Market Session
Ocean Biomedical (NASDAQ:OCEA) stock rose 37.6% to $2.16 during Friday's after-market session. The company's market cap stands at $73.6 million. NeuBase Therapeutics and Virax Biolabs Group also moved upwards. Losers include Telesis Bio and Celularity.
Benzinga · 02/23 21:31
China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split
China Pharma Holdings Inc. Expects to implement a 1-for-5 reverse stock split on its common stock effective March 6, 2024. Every 5 shares of the Company's issued and outstanding common stock will automatically be converted into one share. No fractional shares will be issued as a result of the split. Trading in the stock will continue on the NYSE American under the symbol "CPHI"
PR Newswire · 02/23 21:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Agile Therapeutics (NASDAQ:AGRX) stock rose 82.4% to $1.81 during Thursday's pre-market session. The company's Q4 earnings came out today. Venus Concept stock rose 72.95% and Indivior shares increased by 16.74%.
Benzinga · 02/22 13:05
Weekly Report: what happened at CPHI last week (0212-0216)?
Weekly Report · 02/19 12:53
12 Health Care Stocks Moving In Thursday's After-Market Session
China Pharma Holding (AMEX:CPHI) shares rose 12.7% to $0.12 during Thursday's after-market session. SenesTech (NASDAQ:SNES) shares moved upwards by 7.54%. Modular Medical stock fell 16.3% in the after-markets.
Benzinga · 02/15 21:31
China Pharma: Notice of Effectiveness
Press release · 02/15 14:08
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers BioSig Technologies (NASDAQ:BSGM) stock increased by 7.7% to $0.96 during Monday's after-market session. The company's Q3 earnings report came out today. Alzamend Neuro stock rose 6.56% and G1 Therapeutics stock fell 37.5% during the same period.
Benzinga · 02/12 21:30
Weekly Report: what happened at CPHI last week (0205-0209)?
Weekly Report · 02/12 12:37
More
Webull provides a variety of real-time CPHI stock news. You can receive the latest news about China Pharma through multiple platforms. This information may help you make smarter investment decisions.
About CPHI
China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.